1. Neuropathic pain in cancer: systematic review, performance of screening tools and analysis of symptom profiles 
M.R. Mulvey, E.G. Boland, D. Bouhassira, R. Freynhagen, J. Hardy, M.J. Hjermstad, S. Mercadante, C. Pérez, M.I. Bennett 
British Journal of Anaesthesia 
Volume 119, Issue 4, Pages (October 2017)
DOI: /bja/aex175
Copyright © 2017 The Author(s) Terms and Conditions

2. Fig 1
Flow diagram of systematic literature search results. *The primary reasons for excluding records were: (1) review article, (2) incomplete data summary reported on either clinician assessment of pain type or neuropathic pain screening tool outcome, and (3) analgesic effectiveness trial not designed to evaluate the performance of screening tools with clinician judgement of pain type.
British Journal of Anaesthesia  , DOI: ( /bja/aex175)
Copyright © 2017 The Author(s) Terms and Conditions

3. Fig 2
LANSS and DN4 item selection frequency by pain groups. Frequencies of patients reporting screening tool items by clinician diagnosed pain groups (neuropathic or not neuropathic) for LANSS, DN4 and PDQ. DN4, Douleur Neuropathique en 4 questions; LANSS, Leeds Assessment of Neuropathic Symptoms and Signs; PDQ, painDETECT; APT, Altered Pinprick Threshold; DMA, Dynamic Mechanical Allodynia. All items significantly discriminated between the pain groups (χ2 test P<0.001).
British Journal of Anaesthesia  , DOI: ( /bja/aex175)
Copyright © 2017 The Author(s) Terms and Conditions